HEADER ANTITUMOR PROTEIN 29-JUL-20 7CMW TITLE COMPLEX STRUCTURE OF PARP1 CATALYTIC DOMAIN WITH PAMIPARIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PARP-1,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 1,ARTD1, COMPND 5 DNA ADP-RIBOSYLTRANSFERASE PARP1,NAD(+) ADP-RIBOSYLTRANSFERASE 1, COMPND 6 ADPRT 1,POLY[ADP-RIBOSE] SYNTHASE 1,PROTEIN POLY-ADP- COMPND 7 RIBOSYLTRANSFERASE PARP1; COMPND 8 EC: 2.4.2.30,2.4.2.-; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP1, ADPRT, PPOL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS PARP1, PAMIPARIB, BGB-290, TRANSFERASE, ANTITUMOR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.C.FENG,H.PENG,Y.HONG,Y.LIU REVDAT 3 29-NOV-23 7CMW 1 REMARK REVDAT 2 13-JAN-21 7CMW 1 JRNL REVDAT 1 16-DEC-20 7CMW 0 JRNL AUTH H.WANG,B.REN,Y.LIU,B.JIANG,Y.GUO,M.WEI,L.LUO,X.KUANG,M.QIU, JRNL AUTH 2 L.LV,H.XU,R.QI,H.YAN,D.XU,Z.WANG,C.X.HUO,Y.ZHU,Y.ZHAO,Y.WU, JRNL AUTH 3 Z.QIN,D.SU,T.TANG,F.WANG,X.SUN,Y.FENG,H.PENG,X.WANG,Y.GAO, JRNL AUTH 4 Y.LIU,W.GONG,F.YU,X.LIU,L.WANG,C.ZHOU JRNL TITL DISCOVERY OF PAMIPARIB (BGB-290), A POTENT AND SELECTIVE JRNL TITL 2 POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR IN CLINICAL JRNL TITL 3 DEVELOPMENT. JRNL REF J.MED.CHEM. V. 63 15541 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 33264017 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01346 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15.2_3472 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.16 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.8 REMARK 3 NUMBER OF REFLECTIONS : 18680 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1868 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.1600 - 6.3400 0.83 1312 145 0.1902 0.2317 REMARK 3 2 6.3400 - 5.0400 0.92 1356 151 0.2018 0.2506 REMARK 3 3 5.0400 - 4.4000 0.90 1295 144 0.1622 0.1959 REMARK 3 4 4.4000 - 4.0000 0.90 1304 145 0.1640 0.2119 REMARK 3 5 4.0000 - 3.7100 0.90 1290 143 0.1941 0.2619 REMARK 3 6 3.7100 - 3.4900 0.92 1322 147 0.2026 0.2465 REMARK 3 7 3.4900 - 3.3200 0.92 1322 147 0.2146 0.2736 REMARK 3 8 3.3200 - 3.1700 0.93 1302 145 0.2184 0.3011 REMARK 3 9 3.1700 - 3.0500 0.94 1351 150 0.2275 0.2882 REMARK 3 10 3.0500 - 2.9500 0.93 1313 146 0.2399 0.2962 REMARK 3 11 2.9500 - 2.8500 0.92 1302 144 0.2358 0.3060 REMARK 3 12 2.8500 - 2.7700 0.88 1232 138 0.2470 0.2795 REMARK 3 13 2.7700 - 2.7000 0.79 1111 123 0.2369 0.3204 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.272 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.497 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.18 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 5675 REMARK 3 ANGLE : 1.147 7669 REMARK 3 CHIRALITY : 0.060 852 REMARK 3 PLANARITY : 0.007 976 REMARK 3 DIHEDRAL : 26.036 2162 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 3 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN 'A' REMARK 3 SELECTION : CHAIN 'B' REMARK 3 ATOM PAIRS NUMBER : NULL REMARK 3 RMSD : NULL REMARK 3 NCS GROUP : 2 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN 'C' REMARK 3 SELECTION : CHAIN 'D' REMARK 3 ATOM PAIRS NUMBER : NULL REMARK 3 RMSD : NULL REMARK 3 NCS GROUP : 3 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN 'E' REMARK 3 SELECTION : CHAIN 'F' REMARK 3 ATOM PAIRS NUMBER : NULL REMARK 3 RMSD : NULL REMARK 3 NCS OPERATOR : 2 REMARK 3 REFERENCE SELECTION: CHAIN 'E' REMARK 3 SELECTION : CHAIN 'L' REMARK 3 ATOM PAIRS NUMBER : NULL REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7CMW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 31-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1300017867. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20133 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.20500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.52200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4HHY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2 M DL-MALIC ACID PH 7.0, 0.1 M BIS REMARK 280 -TRIS PROPANE PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.89900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.24750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.21350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.24750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.89900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.21350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 658 REMARK 465 SER A 659 REMARK 465 HIS A 660 REMARK 465 MET A 661 REMARK 465 GLY B 658 REMARK 465 SER B 659 REMARK 465 HIS B 660 REMARK 465 MET B 661 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 722 70.62 -113.67 REMARK 500 LYS A 798 49.58 37.96 REMARK 500 ASN A 856 61.13 67.23 REMARK 500 ASP A 981 51.00 -96.23 REMARK 500 LYS B 798 47.78 39.28 REMARK 500 HIS B 826 47.72 -83.54 REMARK 500 ASP B 914 83.22 -152.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DS9 A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DS9 B 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 1103 DBREF 7CMW A 662 1011 UNP P09874 PARP1_HUMAN 662 1011 DBREF 7CMW B 662 1011 UNP P09874 PARP1_HUMAN 662 1011 SEQADV 7CMW GLY A 658 UNP P09874 EXPRESSION TAG SEQADV 7CMW SER A 659 UNP P09874 EXPRESSION TAG SEQADV 7CMW HIS A 660 UNP P09874 EXPRESSION TAG SEQADV 7CMW MET A 661 UNP P09874 EXPRESSION TAG SEQADV 7CMW ALA A 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQADV 7CMW GLY B 658 UNP P09874 EXPRESSION TAG SEQADV 7CMW SER B 659 UNP P09874 EXPRESSION TAG SEQADV 7CMW HIS B 660 UNP P09874 EXPRESSION TAG SEQADV 7CMW MET B 661 UNP P09874 EXPRESSION TAG SEQADV 7CMW ALA B 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQRES 1 A 354 GLY SER HIS MET LYS SER LYS LEU PRO LYS PRO VAL GLN SEQRES 2 A 354 ASP LEU ILE LYS MET ILE PHE ASP VAL GLU SER MET LYS SEQRES 3 A 354 LYS ALA MET VAL GLU TYR GLU ILE ASP LEU GLN LYS MET SEQRES 4 A 354 PRO LEU GLY LYS LEU SER LYS ARG GLN ILE GLN ALA ALA SEQRES 5 A 354 TYR SER ILE LEU SER GLU VAL GLN GLN ALA VAL SER GLN SEQRES 6 A 354 GLY SER SER ASP SER GLN ILE LEU ASP LEU SER ASN ARG SEQRES 7 A 354 PHE TYR THR LEU ILE PRO HIS ASP PHE GLY MET LYS LYS SEQRES 8 A 354 PRO PRO LEU LEU ASN ASN ALA ASP SER VAL GLN ALA LYS SEQRES 9 A 354 ALA GLU MET LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA SEQRES 10 A 354 TYR SER LEU LEU ARG GLY GLY SER ASP ASP SER SER LYS SEQRES 11 A 354 ASP PRO ILE ASP VAL ASN TYR GLU LYS LEU LYS THR ASP SEQRES 12 A 354 ILE LYS VAL VAL ASP ARG ASP SER GLU GLU ALA GLU ILE SEQRES 13 A 354 ILE ARG LYS TYR VAL LYS ASN THR HIS ALA THR THR HIS SEQRES 14 A 354 ASN ALA TYR ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE SEQRES 15 A 354 GLU ARG GLU GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS SEQRES 16 A 354 GLN LEU HIS ASN ARG ARG LEU LEU TRP HIS GLY SER ARG SEQRES 17 A 354 THR THR ASN PHE ALA GLY ILE LEU SER GLN GLY LEU ARG SEQRES 18 A 354 ILE ALA PRO PRO GLU ALA PRO VAL THR GLY TYR MET PHE SEQRES 19 A 354 GLY LYS GLY ILE TYR PHE ALA ASP MET VAL SER LYS SER SEQRES 20 A 354 ALA ASN TYR CYS HIS THR SER GLN GLY ASP PRO ILE GLY SEQRES 21 A 354 LEU ILE LEU LEU GLY GLU VAL ALA LEU GLY ASN MET TYR SEQRES 22 A 354 GLU LEU LYS HIS ALA SER HIS ILE SER LYS LEU PRO LYS SEQRES 23 A 354 GLY LYS HIS SER VAL LYS GLY LEU GLY LYS THR THR PRO SEQRES 24 A 354 ASP PRO SER ALA ASN ILE SER LEU ASP GLY VAL ASP VAL SEQRES 25 A 354 PRO LEU GLY THR GLY ILE SER SER GLY VAL ASN ASP THR SEQRES 26 A 354 SER LEU LEU TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA SEQRES 27 A 354 GLN VAL ASN LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN SEQRES 28 A 354 PHE LYS THR SEQRES 1 B 354 GLY SER HIS MET LYS SER LYS LEU PRO LYS PRO VAL GLN SEQRES 2 B 354 ASP LEU ILE LYS MET ILE PHE ASP VAL GLU SER MET LYS SEQRES 3 B 354 LYS ALA MET VAL GLU TYR GLU ILE ASP LEU GLN LYS MET SEQRES 4 B 354 PRO LEU GLY LYS LEU SER LYS ARG GLN ILE GLN ALA ALA SEQRES 5 B 354 TYR SER ILE LEU SER GLU VAL GLN GLN ALA VAL SER GLN SEQRES 6 B 354 GLY SER SER ASP SER GLN ILE LEU ASP LEU SER ASN ARG SEQRES 7 B 354 PHE TYR THR LEU ILE PRO HIS ASP PHE GLY MET LYS LYS SEQRES 8 B 354 PRO PRO LEU LEU ASN ASN ALA ASP SER VAL GLN ALA LYS SEQRES 9 B 354 ALA GLU MET LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA SEQRES 10 B 354 TYR SER LEU LEU ARG GLY GLY SER ASP ASP SER SER LYS SEQRES 11 B 354 ASP PRO ILE ASP VAL ASN TYR GLU LYS LEU LYS THR ASP SEQRES 12 B 354 ILE LYS VAL VAL ASP ARG ASP SER GLU GLU ALA GLU ILE SEQRES 13 B 354 ILE ARG LYS TYR VAL LYS ASN THR HIS ALA THR THR HIS SEQRES 14 B 354 ASN ALA TYR ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE SEQRES 15 B 354 GLU ARG GLU GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS SEQRES 16 B 354 GLN LEU HIS ASN ARG ARG LEU LEU TRP HIS GLY SER ARG SEQRES 17 B 354 THR THR ASN PHE ALA GLY ILE LEU SER GLN GLY LEU ARG SEQRES 18 B 354 ILE ALA PRO PRO GLU ALA PRO VAL THR GLY TYR MET PHE SEQRES 19 B 354 GLY LYS GLY ILE TYR PHE ALA ASP MET VAL SER LYS SER SEQRES 20 B 354 ALA ASN TYR CYS HIS THR SER GLN GLY ASP PRO ILE GLY SEQRES 21 B 354 LEU ILE LEU LEU GLY GLU VAL ALA LEU GLY ASN MET TYR SEQRES 22 B 354 GLU LEU LYS HIS ALA SER HIS ILE SER LYS LEU PRO LYS SEQRES 23 B 354 GLY LYS HIS SER VAL LYS GLY LEU GLY LYS THR THR PRO SEQRES 24 B 354 ASP PRO SER ALA ASN ILE SER LEU ASP GLY VAL ASP VAL SEQRES 25 B 354 PRO LEU GLY THR GLY ILE SER SER GLY VAL ASN ASP THR SEQRES 26 B 354 SER LEU LEU TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA SEQRES 27 B 354 GLN VAL ASN LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN SEQRES 28 B 354 PHE LYS THR HET DS9 A1101 22 HET GOL A1102 6 HET DS9 B1101 22 HET GOL B1102 6 HET GOL B1103 6 HETNAM DS9 (2R)-14-FLUORO-2-METHYL-6,9,10,19- HETNAM 2 DS9 TETRAZAPENTACYCLO[14.2.1.02,6.08,18.012,17]NONADECA- HETNAM 3 DS9 1(18),8,12(17),13,15-PENTAEN-11-ONE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 DS9 2(C16 H15 F N4 O) FORMUL 4 GOL 3(C3 H8 O3) FORMUL 8 HOH *82(H2 O) HELIX 1 AA1 PRO A 666 PHE A 677 1 12 HELIX 2 AA2 ASP A 678 TYR A 689 1 12 HELIX 3 AA3 PRO A 697 LEU A 701 5 5 HELIX 4 AA4 SER A 702 GLN A 722 1 21 HELIX 5 AA5 SER A 725 ILE A 740 1 16 HELIX 6 AA6 ASN A 754 ARG A 779 1 26 HELIX 7 AA7 ASP A 788 LEU A 797 1 10 HELIX 8 AA8 SER A 808 THR A 821 1 14 HELIX 9 AA9 GLY A 843 LYS A 849 1 7 HELIX 10 AB1 PRO A 850 LYS A 852 5 3 HELIX 11 AB2 ARG A 865 THR A 867 5 3 HELIX 12 AB3 ASN A 868 GLY A 876 1 9 HELIX 13 AB4 PRO A 885 TYR A 889 5 5 HELIX 14 AB5 MET A 900 ASN A 906 1 7 HELIX 15 AB6 TYR A 907 HIS A 909 5 3 HELIX 16 AB7 PRO A 958 ASN A 961 5 4 HELIX 17 AB8 ASP A 993 ALA A 995 5 3 HELIX 18 AB9 PRO B 666 PHE B 677 1 12 HELIX 19 AC1 ASP B 678 TYR B 689 1 12 HELIX 20 AC2 PRO B 697 LEU B 701 5 5 HELIX 21 AC3 SER B 702 GLN B 722 1 21 HELIX 22 AC4 SER B 725 ILE B 740 1 16 HELIX 23 AC5 ASN B 754 GLY B 780 1 27 HELIX 24 AC6 ASP B 788 LEU B 797 1 10 HELIX 25 AC7 SER B 808 THR B 821 1 14 HELIX 26 AC8 GLY B 843 LYS B 849 1 7 HELIX 27 AC9 PRO B 850 LYS B 852 5 3 HELIX 28 AD1 ARG B 865 THR B 867 5 3 HELIX 29 AD2 ASN B 868 GLY B 876 1 9 HELIX 30 AD3 PRO B 885 TYR B 889 5 5 HELIX 31 AD4 MET B 900 ASN B 906 1 7 HELIX 32 AD5 TYR B 907 HIS B 909 5 3 HELIX 33 AD6 PRO B 958 ASN B 961 5 4 HELIX 34 AD7 ASP B 993 ALA B 995 5 3 SHEET 1 AA1 5 THR A 799 VAL A 803 0 SHEET 2 AA1 5 TYR A 829 ARG A 841 -1 O LYS A 838 N LYS A 802 SHEET 3 AA1 5 VAL A 997 PHE A1009 -1 O LEU A1002 N PHE A 837 SHEET 4 AA1 5 ILE A 916 ALA A 925 -1 N GLY A 917 O LEU A1005 SHEET 5 AA1 5 ARG A 857 SER A 864 -1 N HIS A 862 O LEU A 920 SHEET 1 AA2 4 ILE A 895 PHE A 897 0 SHEET 2 AA2 4 GLU A 988 VAL A 991 -1 O VAL A 991 N ILE A 895 SHEET 3 AA2 4 SER A 947 GLY A 950 -1 N VAL A 948 O ILE A 990 SHEET 4 AA2 4 MET A 929 LEU A 932 1 N LEU A 932 O LYS A 949 SHEET 1 AA3 3 GLY A 974 SER A 976 0 SHEET 2 AA3 3 GLY A 952 PRO A 956 -1 N THR A 955 O ILE A 975 SHEET 3 AA3 3 LEU A 984 TYR A 986 1 O LEU A 985 N THR A 954 SHEET 1 AA4 2 ILE A 962 LEU A 964 0 SHEET 2 AA4 2 VAL A 967 VAL A 969 -1 O VAL A 969 N ILE A 962 SHEET 1 AA5 5 THR B 799 VAL B 803 0 SHEET 2 AA5 5 TYR B 829 ARG B 841 -1 O GLU B 840 N ASP B 800 SHEET 3 AA5 5 VAL B 997 PHE B1009 -1 O LYS B1004 N ILE B 834 SHEET 4 AA5 5 ILE B 916 ALA B 925 -1 N GLY B 917 O LEU B1005 SHEET 5 AA5 5 ARG B 857 SER B 864 -1 N HIS B 862 O LEU B 920 SHEET 1 AA6 4 ILE B 895 PHE B 897 0 SHEET 2 AA6 4 GLU B 988 VAL B 991 -1 O VAL B 991 N ILE B 895 SHEET 3 AA6 4 SER B 947 GLY B 950 -1 N GLY B 950 O GLU B 988 SHEET 4 AA6 4 MET B 929 LEU B 932 1 N LEU B 932 O LYS B 949 SHEET 1 AA7 3 GLY B 974 SER B 976 0 SHEET 2 AA7 3 GLY B 952 PRO B 956 -1 N THR B 955 O ILE B 975 SHEET 3 AA7 3 LEU B 984 TYR B 986 1 O LEU B 985 N THR B 954 SHEET 1 AA8 2 ILE B 962 LEU B 964 0 SHEET 2 AA8 2 VAL B 967 VAL B 969 -1 O VAL B 969 N ILE B 962 SITE 1 AC1 11 HIS A 862 GLY A 863 TYR A 889 TYR A 896 SITE 2 AC1 11 PHE A 897 ALA A 898 LYS A 903 SER A 904 SITE 3 AC1 11 TYR A 907 GLU A 988 GOL A1102 SITE 1 AC2 7 ASP A 766 ALA A 880 LYS A 893 GLY A 894 SITE 2 AC2 7 TYR A 896 DS9 A1101 HOH A1227 SITE 1 AC3 11 HIS B 862 GLY B 863 TYR B 889 TYR B 896 SITE 2 AC3 11 PHE B 897 ALA B 898 LYS B 903 SER B 904 SITE 3 AC3 11 TYR B 907 GLU B 988 GOL B1102 SITE 1 AC4 7 ASP B 766 ALA B 880 TYR B 889 LYS B 893 SITE 2 AC4 7 GLY B 894 DS9 B1101 HOH B1201 SITE 1 AC5 6 ASN B 767 ASP B 770 HIS B 862 SER B 864 SITE 2 AC5 6 ASN B 868 HOH B1214 CRYST1 47.798 92.427 164.495 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020921 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010819 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006079 0.00000